WO2007104898A3 - Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques - Google Patents

Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques Download PDF

Info

Publication number
WO2007104898A3
WO2007104898A3 PCT/FR2007/050930 FR2007050930W WO2007104898A3 WO 2007104898 A3 WO2007104898 A3 WO 2007104898A3 FR 2007050930 W FR2007050930 W FR 2007050930W WO 2007104898 A3 WO2007104898 A3 WO 2007104898A3
Authority
WO
WIPO (PCT)
Prior art keywords
mass
topical cosmetic
formula
reducing
characterising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/050930
Other languages
English (en)
Other versions
WO2007104898A2 (fr
Inventor
Alicia Roso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Publication of WO2007104898A2 publication Critical patent/WO2007104898A2/fr
Publication of WO2007104898A3 publication Critical patent/WO2007104898A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulation topique, cosmétique et/ou pharmaceutique, caractérisée en ce qu'elle comprend pour 100 % de sa masse: de 0,05% à 10% massique d'un composé de formule (I): ou d'un de ses sels, dans laquelle R1 représente la chaîne caractérisante d'un acide gras, saturé ou insaturé, linéaire ou ramifié, comportant de 3 à 30 atomes de carbone, R2 représente la chaîne caractérisante d'un acide aminé, R3 représente un atome d'hydrogène, un radical méthyle ou bien R3 constitue avec R2 et N, la chaîne caractérisante d'un acide aminé cyclique, m est compris entre 1 et 50 ou d'un mélange desdits composés de formule (I) ou de leurs sels; de 0,1% à 20% massique de silicate de magnésium et d'aluminium; et jusqu'à 70% massique d'un ou plusieurs ingrédients topiquement acceptables. Utilisation comme agent déodorant, de silicate de magnésium et d'aluminium, dans une formulation topique cosmétique et/ou pharmaceutique comprenant entre 0,05% à 10% massique, plus particulièrement de 0,1% à 5% massique et tout particulièrement de 1% à 5% massique d'au moins un composé de formule (I). Procédé pour réduire l'odeur induite par la présence d'un composé de formule (I), dans une formulation topique cosmétique et/ou pharmaceutique en comprenant caractérisé en ce que l'on incorpore dans ladite formulation, du silicate de magnésium et d'aluminium.
PCT/FR2007/050930 2006-03-16 2007-03-15 Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques Ceased WO2007104898A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0650890 2006-03-16
FR0650890A FR2898491A1 (fr) 2006-03-16 2006-03-16 Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques et formulations a faible odeur

Publications (2)

Publication Number Publication Date
WO2007104898A2 WO2007104898A2 (fr) 2007-09-20
WO2007104898A3 true WO2007104898A3 (fr) 2007-11-01

Family

ID=37121643

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/050930 Ceased WO2007104898A2 (fr) 2006-03-16 2007-03-15 Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques

Country Status (2)

Country Link
FR (1) FR2898491A1 (fr)
WO (1) WO2007104898A2 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03161421A (ja) * 1989-11-16 1991-07-11 Shiseido Co Ltd 頭部用組成物
JP2002265352A (ja) * 2001-03-13 2002-09-18 Kose Corp クリーム状洗浄剤組成物
EP1449517A1 (fr) * 2003-02-21 2004-08-25 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Utilisation de N-Lauroyl aminoacides comme actif cosmétique et pharmaceutique aminissant
EP1449518A1 (fr) * 2003-02-21 2004-08-25 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Utilisation de N-octanoyl aminoacides comme actif cosmétique et pharmaceutique amincissant
FR2869229A1 (fr) * 2004-04-26 2005-10-28 Sederma Soc Par Actions Simpli Utilisation d'un inducteur des ugt par voie topique
FR2873575A1 (fr) * 2004-07-28 2006-02-03 Miyoshi Kasei Inc Poudre enrobee et produit cosmetique la contenant

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03161421A (ja) * 1989-11-16 1991-07-11 Shiseido Co Ltd 頭部用組成物
JP2002265352A (ja) * 2001-03-13 2002-09-18 Kose Corp クリーム状洗浄剤組成物
EP1449517A1 (fr) * 2003-02-21 2004-08-25 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Utilisation de N-Lauroyl aminoacides comme actif cosmétique et pharmaceutique aminissant
EP1449518A1 (fr) * 2003-02-21 2004-08-25 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Utilisation de N-octanoyl aminoacides comme actif cosmétique et pharmaceutique amincissant
FR2869229A1 (fr) * 2004-04-26 2005-10-28 Sederma Soc Par Actions Simpli Utilisation d'un inducteur des ugt par voie topique
FR2873575A1 (fr) * 2004-07-28 2006-02-03 Miyoshi Kasei Inc Poudre enrobee et produit cosmetique la contenant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199134, Derwent World Patents Index; AN 1991-248675, XP002409301 *

Also Published As

Publication number Publication date
FR2898491A1 (fr) 2007-09-21
WO2007104898A2 (fr) 2007-09-20

Similar Documents

Publication Publication Date Title
EP1340755A4 (fr) Agents de traitement des infections a helicobacter
SG151286A1 (en) 5-substituted-2-phenylamino-benzamide as mek inhibitor
WO2010136474A3 (fr) Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine
PT2058317E (pt) Derivado de éster do ácido aminofosfórico e modulador de receptor s1p contendo o mesmo como ingrediente activo
PL2041133T3 (pl) Pochodne imidazo[1,2-a]pirydyno-2-karboksamidów, ich wytwarzanie i zastosowanie terapeutyczne
WO2007098591A3 (fr) Formulation topique pour les ongles
TW200745097A (en) 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors
MX2009003794A (es) Composicion de prostaglandina e estabilizada.
WO2009014105A1 (fr) Nouvel acide carboxylique et composition d'antidépresseur contenant cet acide en tant qu'ingrédient actif
WO2007104879A3 (fr) Composition pulvérulente d'aminoacides n-acylés, utilisation pour préparer des formulations cosmétiques et/ou pharmaceutiques
WO2008133297A1 (fr) Agent thérapeutique ou prophylactique de la dyskinésie
DE60123827D1 (en) 1-methylcarbapenemderivate
BRPI0506496A (pt) conservantes antimicrobianos para obtenção de formulação de multidose usando beta-ciclodextrinas para formas de dosagem lìquidas
WO2007104898A3 (fr) Procede pour reduire l'odeur induite par les lipoaminoacides dans les formulations topiques cosmetiques et/ou pharmaceutiques
WO2008093655A1 (fr) Composé polyol et agent pharmaceutique
BRPI0516942A (pt) método e composição para reduzir o peso corporal em um mamìfero
BR9917315A (pt) Composições medicinais para liberação imediata para uso oral
BRPI0519819B8 (pt) composição aquosa de amaciamento de tecidos
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
EP1707560A4 (fr) Derive d'acide hydroyamique et inhibiteur de generation d'age contenant le derive
BRPI0519248A2 (pt) formulaÇço oral de liberaÇço imediata de um composto ativo, e, mÉtodo para a preparaÇço de uma formulaÇço
NO20060456L (no) Ren D-(17a)-13-etyl-17-hydroksy-18,19-dinorpregn-4-en-20-yn-3-on-3E og 3Z-oksimisomerer, samt fremgangsmater for syntesene av blandingen av isomerer og de rene isomerene
WO2007138031A3 (fr) N-(alkylthioalkyl)amides de l'acide menthane carboxylique et leur utilisation en tant qu'ingrédients actifs de refroidissement physiologiquement actifs
ATE500833T1 (de) Pharmazeutische zusammensetzungen zur verhütung oder behandlung von hirnödemen
BRPI0517103A (pt) método e composição para reduzir o peso corporal em um mamìfero

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07731746

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07731746

Country of ref document: EP

Kind code of ref document: A2